How Nandrolone Affects Progesterone

Nandrolone binds progesterone receptors (it is a progestin) but does NOT raise serum progesterone levels. The community confusion between 'progestogenic activity' and 'elevated progesterone' is widespread. Serum progesterone testing is not useful on nandrolone. Prolactin is the actionable marker.

The Mechanism

Nandrolone is a 19-nortestosterone derivative, and like other 19-nor compounds, it binds the progesterone receptor with measurable affinity. Attardi et al. (2006) confirmed that 19-norandrogens "bound with high affinity to both rabbit and human PR" and stimulated PR-mediated transcription.

This is progestogenic activity, not progesterone production. Nandrolone acts as a progesterone receptor agonist (it activates the receptor) but it does not stimulate the body's production of progesterone itself. Serum progesterone levels in men on nandrolone remain in the normal male reference range (typically 0.2-1.4 nmol/L or 0.1-0.5 ng/mL) because nandrolone does not affect the adrenal or testicular pathways that produce progesterone.

The community confusion stems from a logical shortcut: "nandrolone is a progestin, progestins affect prolactin, therefore nandrolone raises prolactin via progesterone." The pharmacology runs the opposite direction. Giguere et al. (1982) demonstrated that the synthetic progestin R5020 actually inhibits prolactin release by 33-50% at the pituitary level. Sitruk-Ware et al. (1985) confirmed that lynestrenol, a 19-nortestosterone derivative, significantly decreases prolactin.

Nandrolone's prolactin elevation occurs via a different pathway: hypothalamic opioid receptor modulation. Magnusson et al. (2009) showed nandrolone dose-dependently alters kappa opioid receptor density in the hypothalamus, reducing dopaminergic tone, which disinhibits pituitary prolactin secretion.

Expected Changes

Serum progesterone on nandrolone:

  • No significant change from baseline in most users
  • Remains within normal male reference range (0.2-1.4 nmol/L)
  • Nandrolone does not stimulate progesterone production

Progesterone receptor activation (not measurable on standard blood tests):

  • Nandrolone directly activates progesterone receptors at tissue level
  • This contributes to progestogenic side effects (water retention, gynecomastia risk)
  • The receptor activation is from nandrolone itself, not from elevated serum progesterone

Monitoring Guidance

Do not order serum progesterone as a monitoring marker on nandrolone cycles. It will return a normal result and provide no actionable information about progestogenic side effects.

Order prolactin instead. Prolactin is the actionable bloodwork marker for 19-nor-related sexual dysfunction, gynecomastia risk, and progestogenic side effect management.

If you have already tested progesterone on nandrolone and it came back normal: this does not mean you are free of progestogenic effects. The progestogenic activity comes from nandrolone binding the receptor directly, not from elevated circulating progesterone.

Management Strategies

  • Stop testing progesterone on nandrolone cycles. It is not informative and wastes money
  • Test prolactin at baseline and week 4 instead
  • If experiencing progestogenic side effects (nipple sensitivity, mood changes, water retention), check prolactin first
  • If prolactin is normal but progestogenic symptoms persist, the issue is direct PR activation by nandrolone at tissue level, which cannot be detected or managed via blood tests alone
  • Reducing nandrolone dose is the only way to reduce direct PR activation

Clinical Significance

The distinction between progestogenic activity and progesterone elevation is the most commonly misunderstood concept in 19-nor steroid pharmacology. Testing serum progesterone on nandrolone provides no useful information. Prolactin is the only actionable marker.

Frequently Asked Questions

See how this interaction affects your blood work

Upload your blood tests and log your compounds to see personalised interaction data overlaid on your marker trends.

Quick Facts

Effect Direction

Variable

Severity

mild

Dose-Dependent

Reversible